A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is not in compliance with FDA standards.
As we start the day, we're reminded that "Every new day should be unwrapped like a precious gift" and we're looking for stimulating news.
Every new day should be unwrapped like a precious gift.
We're off the Pharmalot campus today, gearing up for interesting discussions.
Author's summary: Novo Nordisk's Indiana plant faces FDA compliance issues.